Protagonist Therapeutics Inc (PTGX)
45.50
+3.85
(+9.24%)
USD |
NASDAQ |
Nov 22, 14:42
Protagonist Therapeutics Total Liabilities (Quarterly): 71.94M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 71.94M |
| June 30, 2024 | 73.30M |
| March 31, 2024 | 68.83M |
| December 31, 2023 | 21.27M |
| September 30, 2023 | 27.87M |
| June 30, 2023 | 26.40M |
| March 31, 2023 | 23.69M |
| December 31, 2022 | 32.32M |
| September 30, 2022 | 38.56M |
| June 30, 2022 | 42.53M |
| March 31, 2022 | 46.52M |
| December 31, 2021 | 47.67M |
| September 30, 2021 | 43.52M |
| June 30, 2021 | 46.78M |
| March 31, 2021 | 38.74M |
| December 31, 2020 | 44.86M |
| September 30, 2020 | 47.73M |
| June 30, 2020 | 57.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 72.24M |
| December 31, 2019 | 74.95M |
| September 30, 2019 | 59.27M |
| June 30, 2019 | 63.79M |
| March 31, 2019 | 31.42M |
| December 31, 2018 | 26.96M |
| September 30, 2018 | 24.90M |
| June 30, 2018 | 29.81M |
| March 31, 2018 | 34.62M |
| December 31, 2017 | 43.10M |
| September 30, 2017 | 52.58M |
| June 30, 2017 | 9.449M |
| March 31, 2017 | 7.779M |
| December 31, 2016 | 6.435M |
| September 30, 2016 | 5.349M |
| June 30, 2016 | 4.11M |
| March 31, 2016 | 5.475M |
| December 31, 2015 | 5.249M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.27M
Minimum
Dec 2023
74.95M
Maximum
Dec 2019
47.36M
Average
45.69M
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 108.13B |
| Assembly Biosciences Inc | 74.26M |
| Precision BioSciences Inc | 88.39M |
| Entrada Therapeutics Inc | 132.14M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.86M |
| Shareholders Equity (Quarterly) | 531.92M |
| Current Ratio | 10.70 |